Rare Stroke Statistics in US 2026 | Cases, Types, Symptoms & Facts

Rare Stroke in the US 2026

Rare Stroke Statistics in the US 2026 cover a group of uncommon cerebrovascular conditions that together account for only a small slice of the roughly 795,000 strokes Americans experience each year, yet carry outsized clinical significance because they disproportionately strike young, otherwise healthy adults. Conditions such as cervical artery dissection, cerebral venous sinus thrombosis (CVST), and moyamoya disease rarely make headlines the way common ischemic stroke does, but updated 2026 research — including the newly released AHA 2026 Heart Disease and Stroke Statistics Update — shows these rare subtypes are being diagnosed more frequently than in years past, largely thanks to wider use of advanced neuroimaging.

Unlike typical strokes driven by hypertension, atrial fibrillation, or atherosclerosis, these rare stroke types often stem from arterial tears, unusual clotting disorders, or progressive vessel narrowing that standard risk-factor screening can miss entirely. This report breaks down the latest verified Rare Stroke Statistics in the US 2026 — covering incidence, at-risk populations, symptoms, and outcomes for cervical artery dissection, CVST, and moyamoya disease — using data from peer-reviewed neurology journals, the CDC, and the American Heart Association’s 2026 statistical update.

Interesting Facts About Rare Stroke in the US 2026

Data Source: American Heart Association Stroke Journal, StatPearls/NCBI, Neurology (American Academy of Neurology), CDC Stroke Facts

The numbers above illustrate why rare stroke types demand specialized clinical attention even though they represent a small fraction of the roughly 795,000 annual strokes in the United States. Cervical artery dissection, a tear in the wall of the carotid or vertebral artery, accounts for only about 2% of all ischemic strokes overall, but that share jumps dramatically to as much as 15% to 25% among adults younger than 50 — meaning a disproportionate share of “young stroke” cases trace back to this single rare mechanism rather than the traditional risk factors of hypertension and diabetes that dominate stroke statistics in older populations.

Cerebral venous sinus thrombosis and moyamoya disease show similarly striking demographic skews. CVST’s 3:1 female-to-male ratio and median age of 37 reflect its strong association with pregnancy, postpartum states, and hormonal contraceptive use, while moyamoya disease’s nearly fivefold higher incidence in Asian Americans compared to white Americans highlights a genetic component that researchers continue to investigate through variants such as RNF213. Both conditions remain frequently underdiagnosed, since their symptoms — headache, vision changes, or vague neurological complaints — can easily be mistaken for migraine or other benign conditions until advanced imaging reveals the underlying vascular problem.

Cervical Artery Dissection Statistics in US 2026

Data Source: Stroke (American Heart Association journal), Neurology, EMCrit/American Heart Association Scientific Statement 2024

Cervical Artery Dissection Share of Ischemic Stroke, by Age Group
All Ages           |####                    |  ~2%
Adults Under 50    |################        | up to 25%

Cervical artery dissection (CeAD) — a tear in the inner lining of the carotid or vertebral artery that allows blood to pool between the vessel’s layers — stands out as the single most important rare stroke cause among young and middle-aged adults. While it accounts for just 2% of ischemic strokes across the full population, a population-based study using the Rochester Epidemiology Project found a 4-fold increase in detected spontaneous cervical artery dissections between 2002 and 2020, a trend researchers attribute primarily to the growing availability of noninvasive vessel imaging rather than a true rise in incidence. Ten-year outcome data from a real-world cohort found that 68% of dissection patients experienced some ischemic event — split roughly between transient ischemic attacks, minor strokes, and major strokes — while 93% were managed medically with anticoagulants or antiplatelet therapy rather than surgery.

Long-term prognosis for cervical artery dissection is generally favorable compared to other stroke causes, with a 71% ten-year survival rate and a 70% ten-year stroke/death-free survival rate in recent cohort data, though patients with dissections of the common carotid artery specifically showed significantly worse outcomes than those with dissections elsewhere in the cervical arteries. The condition’s strong 3:1 female predominance and frequent occurrence after seemingly trivial trauma — a sudden neck movement, chiropractic manipulation, or even vigorous coughing — makes it a diagnostic challenge that clinicians increasingly screen for when evaluating stroke in patients under 50 who lack traditional cardiovascular risk factors. Readers wanting fuller context on how these younger-onset, higher-recovery-potential strokes compare with the broader national stroke burden can see our Stroke Statistics in the US report, which documents a 14.6% rise in stroke prevalence among adults aged 18–44 nationally.

Cerebral Venous Sinus Thrombosis Statistics in US 2026

Data Source: StatPearls/NCBI Bookshelf, Cureus (Epidemiology of Cerebral Venous Sinus Thrombosis 2021–2023), Stroke journal

CVST Incidence Comparison (per 100,000 person-years, approx.)
General Population        |#                       | 0.3-0.5
Pregnant/Postpartum Women |############            | 12.0

Cerebral venous sinus thrombosis (CVST) occurs when a blood clot forms in the brain’s dural venous sinuses, blocking normal venous drainage and potentially causing intracranial hypertension, venous infarction, or hemorrhage. Classic incidence estimates place CVST at just 3 to 4 cases per million people annually, but a 2016 retrospective population-based study found the true incidence to be considerably higher than previously reported, likely reflecting more complete case ascertainment through comprehensive neuroimaging review rather than a genuine rise in disease frequency. The condition’s association with pregnancy is particularly notable: the incidence during the peripartum and postpartum period reaches roughly 12 cases per 100,000 deliveries, nearly matching the rate of peripartum arterial stroke and reinforcing why obstetric and emergency physicians are trained to maintain a high index of suspicion for CVST in postpartum patients presenting with severe headache.

A 2025 analysis of emergency department encounters using a large, de-identified electronic health record database found that CVST, while still rare, “occurs more frequently in older adults than previously thought,” challenging the historical assumption that the condition is almost exclusively a disease of young women. Headache remained the most common chief complaint across the cohort, and co-presentation with head injury or malignancy was frequently observed, underscoring how varied and nonspecific CVST’s clinical presentation can be. Most patients in contemporary cohorts underwent neuroimaging and received anticoagulation therapy as first-line treatment, consistent with the American Heart Association’s 2024 scientific statement on cerebral venous thrombosis diagnosis and management, which continues to guide 2026 clinical practice.

Moyamoya Disease Statistics in US 2026

Data Source: Medscape/eMedicine, Stroke journal, Neurology, CDC Public Health Genomics and Precision Health Knowledge Base

Moyamoya Disease Incidence by US Ethnic Group (relative to white baseline = 1.0x)
Asian American   |####################| 4.6x
African American |#########           | 2.2x
White            |####                | 1.0x (baseline)
Hispanic         |##                  | 0.5x

Moyamoya disease, a progressive cerebrovascular disorder characterized by narrowing or occlusion of the arteries at the base of the brain, remains one of the rarest and least understood stroke causes in the United States, with annual incidence estimates ranging from 0.35 to 0.94 cases per 100,000 individuals. The disease derives its name from the Japanese term for “puff of smoke,” describing the hazy appearance of the fragile collateral blood vessels that form as the brain attempts to compensate for the narrowing main arteries — vessels that are prone to both blockage, causing ischemic stroke, and rupture, causing hemorrhagic stroke, particularly in adult patients. A Midwestern US cohort study found 72.3% of moyamoya patients were female, alongside a significantly higher prevalence of autoimmune disease, particularly type 1 diabetes and thyroid disease, compared to the general population.

The ethnic disparities in moyamoya incidence are among the most pronounced of any rare stroke type: Asian Americans face roughly 4.6 times the risk of white Americans, while African Americans face 2.2 times the risk, patterns that mirror the disease’s markedly higher incidence in Japan and other East Asian countries where genetic variants such as RNF213 have been strongly implicated. Outcomes vary considerably by age and presentation — children more often present with ischemic strokes, transient ischemic attacks, or seizures, while adults more frequently experience hemorrhagic strokes from ruptured collateral vessels — and mortality rates reflect that difference, running at approximately 10% in adults compared to 4.3% in children. Perhaps most concerning for long-term quality of life, 50% to 60% of affected individuals experience gradual cognitive decline, presumably from the cumulative effect of recurrent, often silent, strokes over time.

Rare Stroke Recovery and Outcomes Statistics in US 2026

Data Source: Stroke journal, CDC Stroke Facts, American Heart Association 2026 Statistics Update

10-Year Outcomes: Rare Stroke Types vs General Stroke Population (approx.)
Cervical Artery Dissection Survival  |#######################| 71%
General Under-45 Stroke Survival     |#############################| 88-92%
Moyamoya 10-yr Adult Mortality       |###                     | ~10%

Recovery trajectories for these rare stroke types vary considerably by mechanism, reflecting fundamentally different underlying pathologies. Cervical artery dissection patients generally fare better than the broader stroke population might expect given their younger average age, with a 71% ten-year survival rate, though this is somewhat lower than the 88% to 92% survival documented for the general under-45 US stroke population in our Stroke Recovery Statistics in US report — a gap likely explained by dissection’s tendency to affect large-territory vessels and its association with connective tissue disorders that carry their own independent mortality risk. The overwhelming preference for medical management (93%) over surgical intervention reflects how effectively anticoagulant and antiplatelet therapies can stabilize the dissected vessel and allow natural healing over subsequent months.

Moyamoya disease presents a starker long-term picture, with its 10% adult mortality rate and the sobering finding that 50% to 60% of patients experience gradual cognitive decline from repeated, sometimes clinically silent, strokes — a pattern that distinguishes it from single-event stroke types where recovery, once achieved, tends to be more durable. This progressive nature means moyamoya patients typically require ongoing neurological surveillance and, in many cases, surgical revascularization procedures to reduce future stroke risk, a markedly different management philosophy from the largely medication-based approach used for cervical artery dissection and CVST. Given that traditional cardiovascular risk factors like hypertension and high cholesterol — extensively documented in our Heart Disease Statistics in US report — play a much smaller role in these rare stroke types, clinicians increasingly emphasize that a stroke in a young, otherwise healthy patient warrants dedicated vascular imaging rather than the standard risk-factor workup used for older stroke patients.

Disclaimer: This research report is compiled from publicly available sources. While reasonable efforts have been made to ensure accuracy, no representation or warranty, express or implied, is given as to the completeness or reliability of the information. We accept no liability for any errors, omissions, losses, or damages of any kind arising from the use of this report.

Email ID:

Please enable JavaScript in your browser to complete this form.

Email

Email *

SUBSCRIBE